Meta Biomed Co., Ltd. (KOSDAQ:059210)

Market Cap	115.54B +8.0%
Revenue (ttm)	102.95B +9.5%
Net Income	10.99B -51.0%
EPS	437.65 -33.3%
Shares Out	26.14M
PE Ratio	10.10
Forward PE	7.14
Dividend	105.00 (2.31%)
Ex-Dividend Date	Dec 29, 2025

Volume	193,542
Average Volume	131,219
Open	4,580.00
Previous Close	4,555.00
Day's Range	4,400.00 - 4,600.00
52-Week Range	4,065.00 - 6,600.00
Beta	0.72
RSI	46.97
Earnings Date	May 15, 2026

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux...

• Industry: Dental Equipment and Supplies
• Founded: 1990
• Employees: 305
• Stock Exchange: KOSDAQ
• Ticker Symbol: 059210

Financial Performance

In 2025, Meta Biomed's revenue was 102.95 billion, an increase of 9.48% compared to the previous year's 94.04 billion. Earnings were 10.99 billion, a decrease of -50.95%.